| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.006 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.093 | 0.006 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.008 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.091 | 0.008 |